| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917238A2 Sulfonamides |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1344109B1 Onium salts and the use therof as latent acids |
| 05/07/2008 | CN101175746A Process for producing 3-substituted thiophene |
| 05/07/2008 | CN101175720A New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368473 Paclitaxel enhancer compounds |
| 05/06/2008 | US7368472 1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2377803C Phenyl sulfamate derivatives |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/02/2008 | WO2008051489A2 Salt forms of substituted benzothienyl compounds |
| 05/02/2008 | WO2008050600A1 Therapeutic or preventive agent for intractable disease based on oxidative stress-mediated cell death as molecular background |
| 05/02/2008 | WO2007077580A3 Improved process for pure duloxetine hydrochloride |
| 05/01/2008 | US20080103316 Reduction of 4-aryl-4-ketobutanoic acid derivatives utilizing ruthenium containing catalysts |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103049 Benzoyl-Substituted Serineamides |
| 05/01/2008 | US20080100207 cyclopentaphenanthrene-based compound which is adapted for both dry and wet processes, and has excellent thermal stability and good charge transport and emission characteristics |
| 04/30/2008 | EP1916244A1 Thiophene compound having sulfonyl group and process for producing the same |
| 04/30/2008 | EP1916243A1 (e)-n-monoalkyl-3-oxo-3-(2-thienyl)propenamine and process for producing the same and (e,z)-n-monoalkyl-3-oxo-3-(2-thienyl)propenamine and process for producing the same |
| 04/30/2008 | EP1915360A2 Photoactive compounds |
| 04/30/2008 | EP1915355A1 Therapeutic agents |
| 04/30/2008 | EP1915352A1 Compounds for the treatment of alzheimer's disease |
| 04/30/2008 | CN101171339A Method for producing optically active alcohols by means of enzymatic reduction |
| 04/30/2008 | CN101171231A Diacylglycerol acyltransferase inhibitors |
| 04/30/2008 | CN100384821C Cetp activity inhibitors |
| 04/30/2008 | CN100384791C Catalytic hydrogeneration of carbon-heteroatom double bonds |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365094 Rheumatic diseases; antiarthritic agents; autoimmune disorders ; antiproliferative agents; antiinflammatory agents; antiprotozoa agents |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365074 Pyridazine, pyrimidine and pyrazine ethyne compounds |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
| 04/29/2008 | CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2008048990A2 Processes suitable for producing macromolecular antioxidant compositions |
| 04/24/2008 | WO2008048987A1 Processes suitable for producing macromolecular antioxidant compositions |
| 04/24/2008 | WO2008047883A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 04/24/2008 | WO2008047105A1 Crystalline form of benzothiophene compound and process for preparation thereof |
| 04/24/2008 | WO2008009415A3 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 04/24/2008 | WO2002042261A8 PROCESS FOR PREPARING α-(3-ARYLTHIO)-ACETOPHENONES |
| 04/24/2008 | US20080097110 Salt forms of substituted benzothienyl compounds |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080096960 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form |
| 04/24/2008 | US20080096953 N-(2-{2-[(2-Hydroxy-3-isobutyl-3-methyl-4-oxo-cyclobut-1-enyl)-phenyl-methyl]-6-methyl-1H-indol-3-yl}-1,1-dimethyl-ethyl)-acetamide, for example; useful as chymase inhibitors; treatment of allergy, asthma, peripheral arterial occlusive disease, irritable bowel disease |
| 04/24/2008 | US20080096937 For example, 2-{4-[(2-chloro-benzyl)-ethyl-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096917 for plants; 2-(dibenzofuranyl-2-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(indanyl-5-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(3-phenylquinolinyl-6-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; phytopathogenic fungi |
| 04/24/2008 | US20080096889 Histone Deacetylases Inhibitors |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/24/2008 | CA2665011A1 Alkylated heterocyclic reaction products useful as antioxidants |
| 04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
| 04/23/2008 | EP1912958A1 Substituted malononitrile compounds for combating animal pests |
| 04/23/2008 | EP1745006A4 Methods of 1,3-enyne preparation using copper (i) catalysts |
| 04/23/2008 | EP1534716B1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | CN101166724A Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators |
| 04/23/2008 | CN101166722A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
| 04/23/2008 | CN100383665C Onium salts and the use therof as latent acids |
| 04/23/2008 | CN100383138C Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361716 Method of preparing a polymer, method of preparing a compounds, compounds, polymers, and method of manufacturing an electronic device |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | US7361198 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 04/17/2008 | WO2008045671A1 Matrix metalloprotease inhibitors |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008043567A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 04/17/2008 | WO2007115836A3 Tetrahydronaphtol-derivatives and use thereof |
| 04/17/2008 | US20080091035 Process for the preparation of a borylated thiophene |
| 04/17/2008 | US20080090978 Ligand of cyclopentadiene fused to heterocycle with atom(s) of boron, nitrogen, oxygen, aluminum, silicon, phosphorus, sulfur, gallium, germanium, arsenic, selenium, indium, tin, antimony and/or tellurium; coordination catalysts; isotatic, syndiotactic or atactic polyethylene, polypropylene or copolymer |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | DE10234188B4 Oktupolare Moleküle als organische Halbleiter Octupolar molecules as organic semiconductors |
| 04/16/2008 | EP1910447A1 Improved process for substituted polythiophene polymers |
| 04/16/2008 | EP1910328A1 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators |
| 04/16/2008 | EP1910325A2 New pharmaceutical compounds |
| 04/16/2008 | EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof |
| 04/16/2008 | EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 04/16/2008 | EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 04/16/2008 | CN101163699A Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof |
| 04/16/2008 | CN101163690A 苯并噻吩异羟肟酸衍生物 Benzothiophene hydroxamic acid derivatives |
| 04/16/2008 | CN101163471A Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381439C Prepn process of 9,10-dibromo-9,10-dihydro-4H-benzo-[4,5]-suberene-[1,2-b]-thienyl-4-one |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/16/2008 | CN100381409C Synthesis of alpha,beta,beta-trifluorostyrene via in-situ for mation or trifluorovinyl metal halide |
| 04/15/2008 | US7358376 Substituted Thiophene compounds |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
| 04/15/2008 | US7358248 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatases |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/15/2008 | CA2211981C Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols |